Emergent Biosolutions INC (F/K/A Adapt Pharma INC )

Cutting-edge treatments for patients with special medical conditions

Based in PA

🤖

AI Overview

With $130K in lobbying spend across 8 quarterly filings, Emergent Biosolutions INC (F/K/A Adapt Pharma INC ) is an active lobbying client. Their lobbying covers 1 issue area. Active from 2018 to 2019.

$130K

Total Spend

Years Active

Firms Hired

Lobbyists Deployed

Issues Lobbied

Spending Trend

View as table

Year	Lobbying Spend
2018	$90K
2019	$40K

Issues Lobbied

Health Issues

Lobbying Firms

Burrell International Group LLC

Lobbyists

Deborah Burrell

Government Agencies Targeted

These are the government entities that Emergent Biosolutions INC (F/K/A Adapt Pharma INC ) disclosed contacting in their lobbying filings.

HOUSE OF REPRESENTATIVESSENATE

View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues

Opioid and heroin addiction legislation, Naloxone access.

House and Senate Opioid Packages:

H.R.6 - 115th Congress (2017-2018) SUPPORT for Patients and Communities Act;

S.3120 - 115th Congress (2017-2018) HEAL Act of 2018;

H.R.5925 - 115th Congress (2017-2

HR 6, Labor HHS Appropriations;

CARA 2.0;

POWER Act;

Naloxone access provisions, generally;

Opioid Package, issues relating to: naloxone access, coprescribing/opioid prescribing guidelines,

Judiciar

NDAA - provisions related to biological and chemical defense